SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001401914-19-000058
Filing Date
2019-06-03
Accepted
2019-06-03 16:06:32
Documents
16
Period of Report
2019-06-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dare8-k06032019.htm 8-K 29627
2 EXHIBIT 99.1 corppresentation060319.htm EX-99.1 16428
3 corppresentation060319001.jpg GRAPHIC 85957
4 corppresentation060319002.jpg GRAPHIC 198170
5 corppresentation060319003.jpg GRAPHIC 73597
6 corppresentation060319004.jpg GRAPHIC 101043
7 corppresentation060319005.jpg GRAPHIC 104376
8 corppresentation060319006.jpg GRAPHIC 91807
9 corppresentation060319007.jpg GRAPHIC 119492
10 corppresentation060319008.jpg GRAPHIC 80815
11 corppresentation060319009.jpg GRAPHIC 100250
12 corppresentation060319010.jpg GRAPHIC 108867
13 corppresentation060319011.jpg GRAPHIC 113849
14 corppresentation060319012.jpg GRAPHIC 104589
15 corppresentation060319013.jpg GRAPHIC 84156
16 corppresentation060319014.jpg GRAPHIC 71797
  Complete submission text file 0001401914-19-000058.txt   2030468
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 19873327
SIC: 2834 Pharmaceutical Preparations